To accelerate the development of gene therapies and life-saving drugs, or rapid pandemic response, life science companies can no longer afford to have automation solutions that are siloed and difficult to use.
Instead, they need an automation platform that is fully connected across their entire lab — from its software and data to its people and hardware — and intuitive for anyone to use.